GB0608822D0 - Inhibitors of DHFR - Google Patents

Inhibitors of DHFR

Info

Publication number
GB0608822D0
GB0608822D0 GBGB0608822.3A GB0608822A GB0608822D0 GB 0608822 D0 GB0608822 D0 GB 0608822D0 GB 0608822 A GB0608822 A GB 0608822A GB 0608822 D0 GB0608822 D0 GB 0608822D0
Authority
GB
United Kingdom
Prior art keywords
dhfr
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0608822.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chroma Therapeutics Ltd
Original Assignee
Chroma Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chroma Therapeutics Ltd filed Critical Chroma Therapeutics Ltd
Priority to GBGB0608822.3A priority Critical patent/GB0608822D0/en
Publication of GB0608822D0 publication Critical patent/GB0608822D0/en
Priority to PCT/GB2007/001475 priority patent/WO2007129020A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0608822.3A 2006-05-04 2006-05-04 Inhibitors of DHFR Ceased GB0608822D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0608822.3A GB0608822D0 (en) 2006-05-04 2006-05-04 Inhibitors of DHFR
PCT/GB2007/001475 WO2007129020A1 (en) 2006-05-04 2007-04-23 Pyrimidine derivatives useful as dhfr inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0608822.3A GB0608822D0 (en) 2006-05-04 2006-05-04 Inhibitors of DHFR

Publications (1)

Publication Number Publication Date
GB0608822D0 true GB0608822D0 (en) 2006-06-14

Family

ID=36603918

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0608822.3A Ceased GB0608822D0 (en) 2006-05-04 2006-05-04 Inhibitors of DHFR

Country Status (2)

Country Link
GB (1) GB0608822D0 (en)
WO (1) WO2007129020A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0903480D0 (en) 2009-02-27 2009-04-08 Chroma Therapeutics Ltd Enzyme Inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002068397A1 (en) * 2001-02-28 2002-09-06 Melacure Therapeutics Ab Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors
PL374589A1 (en) * 2001-06-28 2005-10-31 Pliva D.D. 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors
PL1877098T3 (en) * 2005-05-05 2013-09-30 Glaxosmithkline Ip Dev Ltd Alpha aminoacid ester-drug conjugates hydrolysable by carboxylesterase

Also Published As

Publication number Publication date
WO2007129020A1 (en) 2007-11-15

Similar Documents

Publication Publication Date Title
HK1225722A1 (en) Inhibitors of kinase activity
HK1204548A1 (en) Uses of dpp iv inhibitors dpp iv
ZA200802585B (en) Pyridopyrimidinone inhibitors of Pl3Kα
IL190292A0 (en) PYRIDOPYRIMIDINONE INHIBITORS OF P13Ka
EP2026843A4 (en) Therapeutic uses of inhibitors of rtp801l
ZA200706345B (en) Amino-pyridines as inhibitors of ß-secretase
GB0621607D0 (en) Inhibitors of c-Met
PT2402319T (en) Dgat inhibitors
EP2051707A4 (en) Inhibitors of plasma kallikrein
EP2083861A4 (en) Antagonists of pcsk9
EP2083859A4 (en) Antagonists of pcsk9
EP2083860A4 (en) Antagonists of pcsk9
EP2106261A4 (en) Antagonists of pcsk9
HK1200440A1 (en) Crystalline forms of inhibitor
IL197869A0 (en) Compositions of chk1 inhibitors
EP2054056A4 (en) Small molecule inhibitors of kynurenine-3-monooxygenase
GB0622084D0 (en) Inhibitors of HSP90
EP2054397A4 (en) Small molecule inhibitors of kynurenine-3-monooxygenase
IL196000A0 (en) 2-arylindole derivatives as npges-i inhibitors
GB0608821D0 (en) DHFR enzyme inhibitors
GB0705854D0 (en) Methods of construction
GB0621205D0 (en) Inhibitors of PLK
GB0608822D0 (en) Inhibitors of DHFR
GB2443299B (en) Method of monodiameter well construction
GB0604901D0 (en) Improved formulation of COMT inhibitors

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)